Stay updated on NVL-520 in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the NVL-520 in ROS1+ NSCLC Clinical Trial page.

Latest updates to the NVL-520 in ROS1+ NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' navigation element has been removed.SummaryDifference0.6%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.6%
- Check16 days agoChange DetectedThe web page has added a facility name and location details, while removing specific location terms and country listings. This indicates a shift towards a more streamlined presentation of location information.SummaryDifference34%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.3%
- Check37 days agoChange DetectedThe study title has been updated to reflect the correct name of the drug, Zidesamtinib (NVL-520), and the revision date has changed from June 29, 2025, to August 3, 2025.SummaryDifference1%
- Check44 days agoChange DetectedThe page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to NVL-520 in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVL-520 in ROS1+ NSCLC Clinical Trial page.